Adaptimmune Therapeutics (ADAP)
NASDAQ: ADAP
· Real-Time Price · USD
0.28
-0.00 (-1.06%)
At close: Jun 09, 2025, 3:58 PM
Adaptimmune Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.27 | -0.46 | -3.45 | 0.97 | -1.83 | -0.93 | -0.97 | -2 | 43.46 | -2.05 | -1.07 | -1.53 | -1.61 | -3.77 | -4.76 | -4.24 | -5.46 |
PEG Ratio | 0.01 | -0.00 | 0.03 | -0.00 | 0.31 | -0.16 | -0.01 | 0.00 | -0.42 | 0.07 | 0.12 | 0.11 | -0.06 | 0.45 | -0.57 | -1.44 | -1.79 |
PS Ratio | 6.95 | 42.79 | 5.94 | 2.09 | 62.62 | 772.93 | 24.12 | 33.30 | 3.78 | 21.73 | 25.20 | 49.26 | 90.28 | 413.43 | 670.85 | 214.31 | 1.9K |
PB Ratio | -1.35 | 11.64 | 3.04 | 2.79 | 14.59 | 4.56 | 2.00 | 1.35 | 2.15 | 2.93 | 1.56 | 1.92 | 1.98 | 2.84 | 3.35 | 2.39 | 2.67 |
P/FCF Ratio | -0.76 | -3.9 | -4.43 | 5.76 | -11.01 | -11.62 | -3.88 | -3.8 | -4.52 | -172.88 | -3.02 | -5.43 | -5.25 | 4.51 | -17.22 | -19.95 | -17.23 |
P/OCF Ratio | -0.76 | -4.03 | -4.46 | 5.66 | -11.13 | -12.28 | -3.91 | -3.9 | -4.83 | 117.34 | -3.67 | -6.61 | -5.93 | 4.37 | -17.85 | -21.08 | -17.71 |
OCF/S Ratio | -9.14 | -10.62 | -1.33 | 0.37 | -5.62 | -62.94 | -6.17 | -8.53 | -0.78 | 0.19 | -6.87 | -7.45 | -15.22 | 94.52 | -37.57 | -10.16 | -107.24 |
Debt / Equity Ratio | -0.62 | 6.26 | 0.93 | 0.49 | 0.97 | 0.64 | 0.29 | 0.21 | 0.27 | 0.28 | 0.20 | 0.17 | 0.16 | 0.12 | 0.11 | 0.08 | 0.07 |
Quick Ratio | 1.79 | 2.80 | 3.82 | 3.09 | 2.81 | 2.83 | 2.92 | 3.44 | 3.34 | 3.94 | 3.88 | 4.34 | 5.28 | 6.63 | 7.27 | 8.11 | 11.43 |
Current Ratio | 2.02 | 2.92 | 3.85 | 3.09 | 2.81 | 2.85 | 2.92 | 3.44 | 3.36 | 3.96 | 4.00 | 4.36 | 5.43 | 6.64 | 7.30 | 8.15 | 11.48 |
Asset Turnover | 0.05 | 0.01 | 0.13 | 0.40 | 0.02 | 0.00 | 0.02 | 0.01 | 0.17 | 0.03 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 |
Interest Coverage | -24.31 | -42.92 | -13.24 | 130.61 | n/a | -10.8K | n/a | n/a | n/a | -26.87 | -132.69 | n/a | -147.87 | -239.46 | -187.47 | -147.79 | -89.15 |
Return on Equity | 1.27 | -6.26 | -0.22 | 0.72 | -1.99 | -1.22 | -0.52 | -0.17 | 0.01 | -0.36 | -0.37 | -0.31 | -0.31 | -0.19 | -0.18 | -0.14 | -0.12 |
Return on Assets | -0.3 | -0.3 | -0.06 | 0.22 | -0.19 | -0.17 | -0.15 | -0.06 | n/a | -0.09 | -0.12 | -0.11 | -0.12 | -0.08 | -0.12 | -0.1 | -0.09 |
Return on Invested Capital | -0.4 | -0.4 | -0.06 | 0.28 | -0.25 | -0.23 | -0.2 | -0.17 | n/a | -0.11 | -0.16 | -0.14 | -0.14 | -0.1 | -0.13 | -0.11 | -0.1 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.88 | 1.00 | 1.00 | 0.98 | 0.50 | -11.34 | 0.61 | 0.56 | 0.96 | -1.09 | -3.74 | -5.27 | -9.28 | -19.82 | -22.45 | -8.33 | -55.47 |
Net Profit Margin | -6.53 | -23.03 | -0.43 | 0.54 | -8.54 | -207.43 | -6.23 | -4.17 | 0.02 | -2.65 | -5.91 | -8.04 | -14.06 | -27.42 | -35.25 | -12.62 | -87.01 |
Pretax Profit Margin | -6.45 | -22.51 | -0.41 | 0.53 | -8.45 | -226.27 | -6.14 | -4.04 | 0.03 | -2.56 | -5.85 | -7.95 | -13.88 | -27.28 | -35.07 | -12.6 | -86.32 |
Operating Profit Margin | -6.28 | -22.82 | -0.36 | 0.54 | -8.68 | -231.83 | -6.32 | -8.75 | 0.03 | -2.47 | -6.14 | -7.9 | -13.98 | -30.25 | -35.06 | -12.7 | -87.3 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -5.86 | -21.1 | -0.31 | 0.55 | -8.18 | -213.94 | -5.98 | -4.09 | -0.04 | -2.13 | -5.92 | -7.62 | -13.53 | -30.25 | -33.85 | -12.24 | -83.99 |